Vaxcyte (PCVX) CTO Harpreet Dhaliwal Surrenders 1,020 Shares

What Happened
Harpreet S. Dhaliwal, Chief Technical Operations Officer at Vaxcyte, surrendered a total of 1,020 shares to the company to satisfy tax withholding obligations when RSUs vested. The transactions: 361 shares at $60.74 on 2026-08-31 (≈ $21,927) and 659 shares at $61.58 on 2026-09-02 (≈ $40,581), total ≈ $62,508. These were dispositions to the issuer for tax withholding (code F), not open-market sales.

Key Details

• Transaction dates and prices: 2026-08-31 — 361 shares @ $60.74; 2026-09-02 — 659 shares @ $61.58.
• Total surrendered: 1,020 shares for ≈ $62,508.
• Filing: Form 4 filed 2026-09-02 (no late-filing flag indicated in the provided data).
• Shares owned after the transactions: not specified in the provided filing excerpt.
• Footnote: F1 — shares surrendered to the issuer to cover tax withholding upon RSU vesting.
• Transaction code: F = tax withholding (routine disposition to satisfy withholding on equity awards).

Context
This was a routine tax-withholding event tied to RSU vesting (shares withheld by the company), not an open-market sale or purchase. Such withholding transactions are common and generally reflect payroll/tax administration rather than a change in the insider’s market view. Purchases or open-market sales typically carry more informational weight for investors than withholding surrenders.